raslss.comRAS LSS Consulting | Strategy Support, Research, Analytics & Consulting

RAS LSS Consulting | Strategy Support, Research, Analytics & Consulting Home Services Industries Pharma MedTech Capabilities Disease Area Strategy Product Strategy Competitive Analysis Positioning Scenario Planning Partnering Support Training Services Perspectives Resources Case Studies Infographics Blogs About Our Difference Our Assurance Mission and Vision Leadership Career Let’s Talk Great Minds. Great Strategy. Great Opportunities... Disease Area Strategy Know More Discover the Secret of Successful Product Launches... Product Strategy Know More Tracking. Monitoring. Interpreting... To Prepare You For The Battlefield Competitive Intelligence Know More Helping in Building a Brand Called 'You' Positioning Know More Unravelling Market Uncertainities To Enable Decision-Making... Workshop Services Know More MINING DATA INTO INSIGHTS TO UNFOLD WHAT MATTERS We help you join the dots... RAS LSS is a niche strategy consultancy serving the global life sciences sector Watch Video About Us Starting with Information Services in 2014, RAS LSS has evolved into a boutique healthcare consulting group. We offer a niche portfolio of Strategy Support and Information Services to Pharmaceutical and Medical Device Companies, throughout the product life-cycle. We elucidate and contextualize current and future market complexities. Leveraging our collective intelligence, we strive to help our clients succeed via Best In Class Situation Analysis Competitively Differentiated Strategy With an outreach across mature and emerging markets, we go the extra mile to create fresh perspectives for our clients in their mission to reduce the global burden of disease. To Deal Or Not To Deal: Lessons Learnt From the Past Deal-making Check out our viewpoint on Rare Diseases , Nanotechnology in Drug Discovery & Design Our Speciality Disease Area Strategy Product Strategy Partnering Support Repurposing / Repositioning Read Our Latest Perspectives... Leveraging Digital Technology, Telemedicine, and Analytics to Transform Clinical Research Telemedicine: A promise of better outcomes or just connected care? Innovations in Pharma Manufacturing: Current Trends and Future Outlook To Deal Or Not To Deal: Lessons Learnt 1 2 3 4 Next » We have put in the hours and the sweat to be credible… > 20 Companies profiled 6 + Therapy Areas 17 + Indications studied > 550 Compounds analyzed > 5500 Clinical trials analyzed > 1500 Partnerships analyzed Meet The Team Zahid joined RAS in 2015 and since then he has been involved in several projects including competitive intelligence, strategy analysis, market analysis. Zahid Nabi CEO & Founder Aditya Bahl Richa has led multiple projects involving strategy analysis, CI, and onsite conference coverage in areas such as Biosimilars, Oncology, Respiratory, and Pain Management . Richa Agrawal Sakshi comes with a wide range of experience in the oncology space pertaining to both solid tumors and blood malignancies (Lung, CRC, Melanoma,AML and MDS). Sakshi Saini Preeti has been with RAS since its inception in 2014. She has worked on several projects involving strategy development, competitive intelligence and market analysis. Preeti Parikh Neha has over 5 years of experience in Lifesciences Business Consulting and Analytics and has gained valuable sector knowledge and expertise during this timeframe. Neha Arora Latest Blogs September 3, 2019 Published by Richa Agrawal at September 3, 2019 0 Categories Digital Health Healthcare Innovation Innovations in Care Delivery Let´s Start with the Definition The integrated management and delivery of quality and safe health services to people in need, along the continuum of disease prevention, diagnosis, treatment, disease-management, rehabilitation and palliative care services, through the different levels and sites of care within the health system, is the universally accepted […] August 26, 2019 Published by Zahid Nabi at August 26, 2019 0 Categories Drug Development Pharma Regulatory The Changing Face of Regulations and Market Access in China China is rapidly emerging as world’s fastest growing pharmaceutical industry. The market is poised to reach $175B by 20221. Faster regulatory approvals and widening market access are some of the major drivers to this growth. China’s rapidly-moving health care industry and unique market characteristics has often required a pharmaceutical company […] August 8, 2019 Published by Neha Arora at August 8, 2019 0 Categories Clinical Research Drug Development Innovation Innovations in Antibiotics – Hope or Too Little Too Late? A brief history Even though Alexander Fleming discovered the first antibiotic penicillin in 1928, it was introduced into the market as a commercial therapeutic for bacterial infection, only in 1940. It was Gerhard Domaghk who developed the first commercial antibacterial Prontosil, a sulfonamide, in 1930s. The introduction of penicillin marked […] August 2, 2019 Published by Aditya Bahl at August 2, 2019 0 Categories Drug Development Classical Pharmacology is Dead: Long Live Phenotypic Screening! The tediously long and risk-laden process of translating a discovery in biology to a marketable medical breakthrough starts with identifying a repertoire of molecules that will bring about the desired effect. What is it, really? Let´s start with the basics – the definition of phenotype itself. A phenotype is […] July 29, 2019 Published by Richa Agrawal at July 29, 2019 0 Categories Drug Delivery Innovation Uncategorized Innovations in Drug Delivery System – Injectables Since 2015, the global injectable/parenteral drug delivery market is growing at a compounded rate of 11.8% and is forecasted to reach $640 million by 2021. It has the potential to soon eclipse oral delivery as the primary route of administration of pharmaceuticals, driven by the increased use of biological drugs.1 […] July 24, 2019 Published by Preeti Parikh at July 24, 2019 0 Categories Pharma Value-Based Contracts in Pharma – A buzz or a game changer? The healthcare industry has been talking about adopting a ‘value-based care’ for some time now.1 Overall, the healthcare systems globally are going through a ‘volume-to-value’ shift with the key aim to improve patient outcomes, cost-effectively. Value-Based Contracting (VBC) and Real-World Evidence (RWE) are the underlying tools to achieve value-based care. […] 1 2 3 ... 11 Next page Case Studies Blogs Competitive Analysis Disease Area Strategy Positioning Development Product Strategy Scenario Planning Copyright 2019 RASLSS × Please fill the form Name * Email * Contact No Role Send Close...